Kymera Therapeutics, Inc.股价拉升11.31% 市值涨2.47亿美元

自选股智能写手07-09

北京时间2024年07月09日21时33分，Kymera Therapeutics, Inc.（KYMR.us）股票出现波动，股价急速拉升11.31%。截至发稿，该股报35.58美元/股，成交量10.1512万股，换手率0.17%，振幅3.63%。最近的财报数据显示，该股实现营业收入10.29百万美元，净利润-48.56百万美元，每股收益-0.69美元，毛利8.79百万美元，市盈率-14.17倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2450028933?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-09 21:33","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2450028933","market":"us","top_or_hot":-1,"title":"Kymera Therapeutics, Inc.股价拉升11.31% 市值涨2.47亿美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年07月09日21时33分，Kymera Therapeutics, Inc.（KYMR.us）股票出现波动，股价急速拉升11.31%。截至发稿，该股报35.58美元/股，成交量10.1512万股，换手率0.17%，振幅3.63%。最近的财报数据显示，该股实现营业收入10.29百万美元，净利润-48.56百万美元，每股收益-0.69美元，毛利8.79百万美元，市盈率-14.17倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092133019f25b705&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kymera Therapeutics, Inc.股价拉升11.31% 市值涨2.47亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKymera Therapeutics, Inc.股价拉升11.31% 市值涨2.47亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-09 21:33 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092133019f25b705&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年07月09日21时33分，Kymera Therapeutics, Inc.（KYMR.us）股票出现波动，股价急速拉升11.31%。截至发稿，该股报35.58美元/股，成交量10.1512万股，换手率0.17%，振幅3.63%。最近的财报数据显示，该股实现营业收入10.29百万美元，净利润-48.56百万美元，每股收益-0.69美元，毛利8.79百万美元，市盈率-14.17倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092133019f25b705&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092133019f25b705&s=b","article_id":"2450028933","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092133019f25b705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2450028933","pubTimestamp":1720531981,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年07月09日21时33分，Kymera Therapeutics, Inc.股票出现波动，股价急速拉升11.31%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。消息层面，截至21时33分，《斯迪富维持Kymera Therapeutics买入评级，维持目标价55美元》资讯为影响Kymera Therapeutics, Inc.的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","KYMR":"Kymera Therapeutics, Inc.","LENZ":"Therapeutics"},"translate_title":"Kymera Therapeutics, Inc. 's stock rises 11.31%, its market value rises by $247 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KYMR":1,"LENZ":1},"content_text":"北京时间2024年07月09日21时33分，Kymera Therapeutics, Inc.（KYMR.us）股票出现波动，股价急速拉升11.31%。截至发稿，该股报35.58美元/股，成交量10.1512万股，换手率0.17%，振幅3.63%。最近的财报数据显示，该股实现营业收入10.29百万美元，净利润-48.56百万美元，每股收益-0.69美元，毛利8.79百万美元，市盈率-14.17倍。机构评级方面，在所有16家参与评级的机构中，69%的券商给予买入建议，31%的券商给予持有建议，无券商给予卖出建议。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Soligenix, Inc.、Uniqure N.V.、Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)涨幅较大，Soligenix, Inc.、Anew Medical, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为2862.56%、91.25%、81.36%，振幅较大的相关个股有Soligenix, Inc.、Uniqure N.V.、Neurosense Therapeutics Ltd.，振幅分别为38.49%、17.03%、16.96%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。 该公司正在推进有针对性的蛋白质降解领域，利用人体固有的蛋白质回收机制来降解失调的致病蛋白质。 Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。 它以无与伦比的靶向和降解难治蛋白质的能力，加速了药物研发，并为患者提供了新的治疗选择。消息层面，截至21时33分，《斯迪富维持Kymera Therapeutics(KYMR.US)买入评级，维持目标价55美元》资讯为影响Kymera Therapeutics, Inc.的重要信息。该信息摘要如下：斯迪富分析师Bradley Canino维持Kymera Therapeutics 买入评级，维持目标价55美元。根据TipRanks数据显示，该分析师近一年总胜率为43.2%，总平均回报率为2.0%。总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2450028933"}